PRNewsWire - Health

Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
Vision Innovation Partners Acquires Eye Care of Delaware
Rising Advanced Prostate Cancer Cases Lead to Urgent Call for Action: Free Treatment is Available Now for Eligible Californians through the IMPACT Program
Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab's Phase 2b Trial (FORTIFY)